Alice Chang

Alice Chang is a Principal Scientist at ArsenalBio, leading the Process Development team for integrated circuit CAR T cells since July 2021, where significant advancements in clinical-scale CAR T manufacturing processes have been achieved. Prior experience includes roles as a Senior Scientist II at Allogene Therapeutics, focusing on allogeneic CAR T process development, and as a Scientist II at Five Prime Therapeutics, where Alice led cell line development initiatives. Alice's academic background includes a PhD in Chemical Engineering from Stanford University, where research involved the biophysical analysis of integrins and various mathematical modeling projects, complemented by a Bachelor's degree in Chemical-Biological Engineering from MIT.